Business Wire

PANASONIC-CORPORATION

16.3.2021 03:15:09 CET | Business Wire | Press release

Share
Panasonic Starts Licensing IP Core for Semiconductors Complying with the IEEE 1901–2020 International Standard

Panasonic Corporation has begun licensing the HD-PLCTM 4*1 IP core required for the design of semiconductors with technologies and functions that comply with the IEEE 1901–2020*2 international standard. This IP core is the fourth generation of the HD-PLC series. Although conventionally HD-PLC have used power lines for transmission, this new series enables transmission through existing metal wires, such as control lines and coaxial cables as well as power lines, expanding its range of applications. This new HD-PLC technology also enables higher speeds, greater distance, and less wiring for wired communications.

By using this IP core, semiconductor and peripheral equipment manufacturers will be able to flexibly meet to a range of IoT service requirements and manufacture products that respond to these needs.

As a wide range of equipment in society becomes digitalized and connects to the IoT devices, communication technologies are becoming increasingly important. While the adoption of wireless technologies such as 5G and high-speed fiber optic internet gains pace, there are some locations in which it is difficult to access wireless communication. Here, the use of existing metal wires—in the walls and ceilings of buildings, underground facilities, and equipment—as communication mediums fulfils a vital role. This IP core is a solution that can rapidly meet to the requirements of the era of IoT, such as higher-speed networks, enhanced security, and internet protocol networks. By combining the IP core with wireless and other technologies, it can help create optimal networks in a range of environments, from living spaces to social infrastructure.

Using its experience and achievements with the HD-PLC 3 IP core, which is currently on the market, in addition to licensing of this new IP core, Panasonic will provide one-stop development support to users which will include proposals for analog front-end circuitry—key to the mounting of semiconductors. Further, as a high-speed wired communication solution, Panasonic will seek to use this technology to expand the adoption of IoT PLC, ultimately applying the technology to large-scale networks that cover living spaces, buildings, factories, smart cities, and other social infrastructure.

This IP core is first licensed to Socionext Inc. This enables the supply of higher performance semiconductors with lower energy consumption using fourth generation HD-PLC. It is expected that these will then be built-in to a range of IoT-connected devices.

Panasonic launched a dedicated website with more information about this technology. Please note that the global IEEE SA and HD-PLC Alliance*3 Webinar will be held on March 18, 2021.

Main Features

  • The standard mode communication band (250 Mbps) can be doubled or quadrupled, allowing a 500 Mbps*4 communication speed in double mode or a maximum of 1 Gbps*4 in quadruple mode on coaxial cable or dedicated line.
  • The standard mode communication band can be compressed on two levels (half or quarter), concentrating and extending the communication distance up to twice*5 the distance in standard mode.
  • With the multi-hop function, it is possible to operate a wide area network of up to 1024 nodes.

Main Specifications

Communication
bandwidth

High-speed mode (1 Gbps, 500 Mbps) *Optional

Standard mode (250 Mbps)

Long-distance mode (2 x or 1.5 x the range of standard mode)

Approved
standards

IEEE 1901-2020

ITU-T G.9972 (Coexistence mechanism for different PLC systems)

ITU-T G.9905 (Multi-hop) *Optional

EN 50561-1:2013 (Dynamic notch and dynamic power control)

Inquiries Regarding IP Core Licensing
IoT PLC Project Help Desk
Email: hd-plc_press@ml.jp.panasonic.com
Website: https://www.panasonic.com/global/business/hd-plc/en.html

*1: HD-PLCTM is the name of the high-speed power line communications system proposed by Panasonic Corporation, and is a trademark or registered trademark of Panasonic Corporation in Japan and other countries. HD-PLCTM 4 is the name of the fourth-generation semiconductor IP core.
*2: Formulated by the IEEE Standards Association (a communication standards subsidiary of the Institute of Electrical and Electronics Engineers) on January 19, 2021, this is a standard for technologies with higher speeds and longer distances than those outlined in IEEE 1901-2010.
IEEE 1901-2020 - IEEE Standard for Broadband over Power Line Networks: Medium Access Control and Physical Layer Specifications: https://standards.ieee.org/standard/1901-2020.html
*3: An alliance formed on September 25, 2007, to support, promote and implement the HD-PLC system for High-Speed Power Line Communications and to ensure mutual compatibility.
Website: https://hd-plc.org/
*4: 500 Mbps and 1 Gbps are theoretical speeds at the physical layer.
*5: Maximum distance may change depending on communication environment.

About Panasonic
Panasonic Corporation is a worldwide leader in the development of diverse electronics technologies and solutions for customers in the consumer electronics, housing, automotive, and B2B businesses. The company, which celebrated its 100th anniversary in 2018, has expanded globally and now operates 528 subsidiaries and 72 associated companies worldwide, recording consolidated net sales of 7.49 trillion yen for the year ended March 31, 2020. Committed to pursuing new value through innovation across divisional lines, the company uses its technologies to create a better life and a better world for its customers. To learn more about Panasonic: https://www.panasonic.com/global .

Source: https://news.panasonic.com/global/press/data/2021/03/en210316-2/en210316-2.html

Related Links
IEEE SA and HD-PLC Alliance Webinar March 2021: Home Networking, Industrial and Building Automation through HD-PLC (High Speed Powerline Communication)
https://standards.ieee.org/events/index.html

[Press Release] Panasonic's Next-generation HD-PLC® , BPL Communication Technology Adopted as IEEE 1901a Standard
https://news.panasonic.com/global/press/data/2019/03/en190325-4/en190325-4.html

Socionext Inc. related press release
https://www.socionext.com/en/pr/sn_pr20210309_01e.pdf

HD-PLC Alliance
https://hd-plc.org/

Link:

ClickThru

Social Media:

https://www.facebook.com/PanasonicCorporation

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

From AI to Autonomous Networks: Mobileum Spark Highlights the Next Frontier of Telecom Intelligence15.10.2026 09:00:00 CEST | Press release

Industry leaders get together to explore how trusted AI, Agentic Intelligence and automation are transforming risk management, accelerating autonomous network operations and unlocking new opportunities for value creation Mobileum Inc. ("Mobileum"), a leading global provider of telecom analytics and network solutions, brought together telecom operators and industry leaders during its Mobileum Spark events series in Lisbon (Portugal) and Frankfurt (Germany), to explore how Artificial Intelligence (AI), Agentic AI and automation are transforming network operations and accelerating the evolution toward autonomous networks. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261015172815/en/ Telecom operators, industry leaders, and Mobileum experts at Mobileum Spark 2026. Focused on Risk Management & Fraud Prevention and Network Testing & Assurance, the events featured customer-led discussions, expert insights, and real-world use case

Merz Therapeutics Announces Completion of Recruitment in Two Phase III Trials Investigating XEOMIN® (incobotulinumtoxinA) for Migraine Prevention15.10.2026 08:00:00 CEST | Press release

Patient recruitment completed six months ahead of schedule in two global Phase III trials for migraine prevention MINT-E and MINT-C are evaluating XEOMIN® (incobotulinumtoxinA) for the preventive treatment of episodic and chronic migraine Trials recruited approximately 1,800 adults across 109 study sites in North America and Europe Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, today announced the completion of patient recruitment in two global Phase III clinical trials, MINT-E (NCT07018700) and MINT-C (NCT07018713), evaluating the efficacy and safety of XEOMIN® (incobotulinumtoxinA) for the prevention of episodic and chronic migraine in adults. The trials recruited approximately 1800 adults across 109 study sites in North America and Europe. Migraine affects around 1.1 billion people worldwide, posing a significant burden on patients, society and healthcare systems.1 Both trials are evaluating the change in monthly migraine days from baseline to Month

Tourism Malaysia and Alipay+ Partner to Accelerate Malaysia’s Digital Tourism Transformation15.10.2026 07:10:00 CEST | Press release

Collaboration will connect seamless payments, in-app digital engagement and AI-powered travel services to enhance the visitor journey, empower businesses of all sizes and unlock wider cross-border commerce opportunities Tourism Malaysia and Alipay+, the unified wallet gateway of Ant International, today signed a Memorandum of Understanding (MoU) to accelerate cross-border commerce and digitalise merchant engagement across Malaysia's tourism economy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261014035900/en/ (From left) Mr Mohd Akbal Setia (Head of VM2026 Secretariat and Senior Director, Advertising & Digital Tourism); Mr Mohd Amirul Rizal Abdul Rahim (Director General, Tourism Malaysia); Mr Danny Chung (General Manager of Alipay+ Global Growth Center and Vice President of Ant International); Mr Michael Guo, Alipay+ General Manager of SEA, South Asia and ANZ, Ant International) As Malaysia welcomes visitors for Visit Mal

PeDRA 2026: Nemolizumab Phase II Data Show Long-Term Symptom Relief for Children Aged 2 to 11 Years With Moderate-to-Severe Atopic Dermatitis15.10.2026 07:00:00 CEST | Press release

Patient-reported outcomes from a phase II study of nemolizumab in children aged 2 to 11 with moderate-to-severe atopic dermatitis show meaningful reductions in itch severity, better sleep and improved quality of life, maintained for a year1 Currently, there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis, despite the high unmet need – the disease can significantly reduce quality of life for children and create burden on their families2-8 These findings expand on the clinical evidence base for nemolizumab, which has multiple global approvals for adult and pediatric patients 12 years of age and older with moderate-to-severe atopic dermatitis, and adults with prurigo nodularis9,10 Galderma (SIX: GALD), the pure-play dermatology category leader, today announced new phase II data showing that nemolizumab provided meaningful improvements in itch, sleep disturbance, and quality of life in children aged 2 to 11 years with moderate-to-severe

Takeda’s ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 115.10.2026 02:30:00 CEST | Press release

− ORZEYFUL is now available in Japan and China following approvals within a month of each other by China’s National Medical Products Administration (NMPA), the U.S. Food and Drug Administration (FDA) and Japan’s Ministry of Health, Labour and Welfare (MHLW) − Discovered by Takeda scientists in Japan, ORZEYFUL is the lead medicine in Takeda’s orexin franchise, with multiple programs for sleep-wake disorders and conditions where orexin biology plays a role − ORZEYFUL set to launch next month in the U.S., following completion of DEA scheduling; Health Authority submissions underway worldwide Takeda (TSE:4502/NYSE:TAK)announced today that ORZEYFUL (oveporexton) is now available in Japan and China for the treatment of narcolepsy type 1 (NT1), providing first access to clinicians to prescribe treatment with the new class of medicine. ORZEYFUL is a first-in-class orexin receptor 2 (OX2R) agonist, in tablet form, designed to treat the underlying orexin deficiency associated with NT1. “We’re ex

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye